Our results are consistent with these studies identifying ZFP36L1 as a tumor suppressor in SCLC, where it also possesses the ability to bind and downregulate mRNAs that promote SCLC neuroendocrine differentiation including INSM1 and SOX2. This evidence concerns the gene SOX2 and small cell lung carcinoma.